Characteristics of study participants at baseline
| Overall (n=102) | Intervention group (n=51) | Control group (n=51) | |
| Male, n (%) | 60 (59%) | 32 (63%) | 28 (55%) |
| Female, n (%) | 42 (41%) | 19 (37%) | 23 (45%) |
| Age, mean (SD) | 54±14.0 | 55±12.4 | 54±15.5 |
| BMI (kg/m2) | 26.7±3.8 | 26.4±3.7 | 27.0±3.9 |
| SBP (mm Hg) | 150.9±11.5 | 151.8±12.6 | 150.0±10.3 |
| DBP (mm Hg) | 91.1±11.3 | 92.7±9.6 | 89.5±12.6 |
| HR (BPM) | 72±10.6 | 73±11.2 | 70.0±10.0 |
| CI (L/min/m2) | 3.1±0.72 | 3.1±0.64 | 3.0±0.80 |
| AS (mm Hg/mL/b) | 0.82±0.33 | 0.82±0.36 | 0.82±0.30 |
| SVRI (dyn s m2/cm5) | 3017±731 | 3057±678 | 2975±720 |
| TBR (%) | 0.78±0.11 | 0.79±0.11 | 0.76±0.10 |
| Diabetes, n (%) | 25 (25%) | 13 (25%) | 12 (24%) |
| CHD, n (%) | 4 (4%) | 2 (4%) | 2 (4%) |
| Stoke, n (%) | 1 (1%) | 1 (2%) | 0 (0%) |
| CKD, n (%) | 9 (9%) | 7 (14%) | 2 (4%) |
The data of the two groups were not statistically significant (p>0.05 for all).
AS, aortic resistance index; BMI, body mass index; CHD, coronary heart disease; CI, cardiac output index; CKD, chronic kidney disease; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure; SVRI, systemic vascular resistance index; TBR, thoracic blood volume saturation.